Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Rocket Pharmaceuticals
RCKT
$367M
| $417K | ﹤0.01% |
16,931
+8,775
| +108% | +$190K |
|
4352
PUT
Globe Life
GL
$13.8B
| $416K | ﹤0.01% |
+4,800
| New | +$415K |
|
4353
PUT
Westlake Corp
WLK
$10.2B
| $416K | ﹤0.01% |
5,000
-400
| -7% | -$39.1K |
|
|
JNCE
4354
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $415K | ﹤0.01% |
64,034
+13,546
| +27% | +$101K |
|
|
CHK
4355
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $415K | ﹤0.01% |
463
-514
| -53% | -$469K |
|
4356
CALL
Lazard
LAZ
$4.24B
| $414K | ﹤0.01% |
8,600
+3,600
| +72% | +$179K |
|
4357
PUT
Boyd Gaming
BYD
$6.03B
| $413K | ﹤0.01% |
12,200
-190,100
| -94% | -$6.79M |
|
4358
Geron
GERN
$982M
| $413K | ﹤0.01% |
235,093
+223,430
| +1,916% | +$974K |
|
4359
CALL
TE Connectivity
TEL
$62B
| $413K | ﹤0.01% |
4,700
+1,400
| +42% | +$129K |
|
|
LKSD
4360
DELISTED
LSC Communications, Inc.
LKSD
| $412K | ﹤0.01% |
37,201
+24,893
| +202% | +$321K |
|
|
TFCF
4361
PUT
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $412K | ﹤0.01% |
9,000
-13,000
| -59% | -$590K |
|
4362
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
| $411K | ﹤0.01% |
6,060
| – | – |
|
|
SA
4363
Seabridge Gold
SA
$3.5B
| $411K | ﹤0.01% |
31,748
+5,041
| +19% | +$58.1K |
|
4364
PUT
Designer Brands
DBI
$311M
| $410K | ﹤0.01% |
12,100
-16,300
| -57% | -$476K |
|
4365
TriCo Bancshares
TCBK
$1.84B
| $410K | ﹤0.01% |
10,617
+7,801
| +277% | +$302K |
|
4366
Kosmos Energy
KOS
$1.51B
| $409K | ﹤0.01% |
43,824
-70,213
| -62% | -$593K |
|
4367
Pembina Pipeline
PBA
$28.4B
| $408K | ﹤0.01% |
11,998
+2,934
| +32% | +$102K |
|
|
RDUS
4368
PUT
DELISTED
Radius Recycling
RDUS
| $408K | ﹤0.01% |
15,100
-1,500
| -9% | -$44.9K |
|
4369
Bristow Group
VTOL
$1.36B
| $408K | ﹤0.01% |
16,524
+12,771
| +340% | +$326K |
|
|
AT
4370
DELISTED
Atlantic Power Corporation
AT
| $407K | ﹤0.01% |
185,070
+174,672
| +1,680% | +$379K |
|
4371
SSR Mining
SSRM
$6.49B
| $406K | ﹤0.01% |
46,652
+24,321
| +109% | +$230K |
|
4372
PUT
Core Laboratories
CLB
$571M
| $405K | ﹤0.01% |
3,500
-37,500
| -91% | -$4.23M |
|
4373
MannKind Corp
MNKD
$1.24B
| $405K | ﹤0.01% |
221,604
+112,114
| +102% | +$172K |
|
4374
PUT
Tower Semiconductor
TSEM
$28.6B
| $405K | ﹤0.01% |
18,600
-1,700
| -8% | -$36.3K |
|
4375
CALL
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $404K | ﹤0.01% |
4,800
-12,300
| -72% | -$1.06M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.